Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:1122 (25 November), doi:10.1136/bmj.39037.700150.3A
In response to Fugh-Berman,1 first of all, for ethical reasons, let me declare my conflict of interests: I am a medical marketing consultant for the pharmaceutical industry in Brazil. As an American trained physician, after my return to my homeland back in the 70s, I could feel the size of ignorance of the poorly informed Brazilian doctors, who are by no means more or less ignorant than doctors from other underdeveloped (or developing, if you wish) countries. Even in well developed countries the quality and the level of information held by doctors is variable and "not all doctors are educated equally."
My specialty is the development of continuing medical education projects for the pharmaceutical companies, which share with me the basic concept of intelligent medical marketing: promote the global understanding of the pathology first and then let the doctors know about your products in a balanced and ethical way. But, like drinking and driving, never mix medical information with product promotion.
Is this an easy task? Obviously not. Most of the drug companies behave just like you said, trying to turn doctors into lapdogs and being very successful on it. How can we transform this promiscuous relationship into an ethical and reliable source of medical information? The answer is strict regulation and intelligent control of educational materials produced by the pharmaceutical industry.
As a member of the National Health Council of the Brazilian Ministry of Health, I am working on a proposal based on the concepts described above for the implementation of regulatory legislation that would allow freedom with responsibility for the pharmaceutical industry to promote continuing medical education projects.
Augusto Pimazoni, Medical Marketing Consultant
1 MED MARKMedical Marketing Consultants, Sao Paulo, Brazil pimazoni@uol.com.br
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.